HZNP - Horizon Therapeutics Public Limited Company (HZNP) CEO Tim Walbert on Q1 2022 Results - Earnings Call Transcript
Horizon Therapeutics Public Limited Company (HZNP) Q1 2022 Earnings Conference Call May 04, 2022 08:00 AM ET Company Participants Tina Ventura - Senior Vice President, Chief Investor Relations Officer Tim Walbert - Chairman, President & Chief Executive Officer Liz Thompson - Executive Vice President, Research & Development Paul Hoelscher - Executive Vice President, Chief Financial Officer Conference Call Participants Chris Schott - JPMorgan Madhu Kumar - Goldman Sachs Yatin Suneja - Guggenheim Ken Cacciatore - Cowen & Company Annabel Samimy - Stifel Jason Gerberry - Bank of America David Amsellem - Piper Sandler Derek Archila - Wells Fargo Akash Tewari - Jefferies Gary Nachman - BMO Capital Markets Presentation Operator Good day, and thank you for standing by. Welcome to the Horizon Therapeutics First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation there will be a question-and-answer session. [Operator
For further details see:
Horizon Therapeutics Public Limited Company (HZNP) CEO Tim Walbert on Q1 2022 Results - Earnings Call Transcript